Factors Affecting Reduction in Sperm Count for Man Treated with Cyclophosphamide (Cytoxan)

Purpose: To evaluate the sperm count in a man treated with cyclophosphamide (Cytoxan) based on the study of Meistrich et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a man treated with cyclophosphamide?

Yes

Body weight

Body height

Total dose of cyclophosphamide that the patient has received

Number of months since the last dose of cyclophosphamide therapy

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Body surface area (Dubois & Dubois formula)

Total dose of cyclophosphamide adjusted for body surface area

The chances that the patient's sperm count will return to normal is

Based on the time interval since the last dose of cytoxan, changes in the patient's sperm count

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Laboratory Tests
- Ovarian Function Score (OFS) of Li et al for a Premenopausal Women with Breast Cancer and Chemotherapy-Associated Amenorrhea
Severity, Prognosis, Stage
- Ovarian Function Score (OFS) of Li et al for a Premenopausal Women with Breast Cancer and Chemotherapy-Associated Amenorrhea
Complications
- Hypogonadism in Male Treated for Cancer

Monitoring

Response To Therapy
- Hypogonadism in Male Treated for Cancer
Adverse Effects
Complication Detection
- Hypogonadism in Male Treated for Cancer
- Ovarian Function Score (OFS) of Li et al for a Premenopausal Women with Breast Cancer and Chemotherapy-Associated Amenorrhea

Specialty

Hematology Oncology
Urology

Objective

risk factors
adverse effects

ICD-10

T45.1 - Poisoning, antineoplastic and immunosuppressive drugs

Info

Purpose: To evaluate the sperm count in a man treated with cyclophosphamide (Cytoxan) based on the study of Meistrich et al.

Specialty: Hematology Oncology, Urology

Objective: risk factors, adverse effects

ICD-10: T45.1,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path